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Abstract
Background: Knowledge on how well we can predict primary postpartum hemorrhage (PPH) can help policy
makers and health providers design current delivery protocols and PPH case management. The purpose of this
paper is to identify risk factors and determine predictive probabilities of those risk factors for primary PPH among
women expecting singleton vaginal deliveries in Egypt.
Methods: From a prospective cohort study, 2510 pregnant women were recruited over a six-month period in
Egypt in 2004. PPH was defined as blood loss ≥ 500 ml. Measures of blood loss were made every 20 minutes for
the first 4 hours after delivery using a calibrated under the buttocks drape. Using all variables available in the
patients’ charts, we divided them in ante-partum and intra-partum factors. We employed logistic regression to
analyze socio-demographic, medical and past obstetric history, and labor and delivery outcomes as potential PPH
risk factors. Post-model predicted probabilities were estimated using the identified risk factors.
Results: We found a total of 93 cases of primary PPH. In multivariate models, ante-partum hemoglobin, history of
previous PPH, labor augmentation and prolonged labor were significantly associated with PPH. Post model
probability estimates showed that even among women with three or more risk factors, PPH could only be
predicted in 10% of the cases.
Conclusions: The predictive probability of ante-partum and intra-partum risk factors for PPH is very low. Prevention
of PPH to all women is highly recommended.
Background
Introduction
Primary postpartum hemorrhage (PPH) is the single lar-
gest contributor to maternal mortality worldwide.
Throughout Africa and Asia, hemorrhage accounts for
30% or more of all maternal deaths, most of which is PPH
[1]. Even if effective antenatal screening existed, hemor-
rhage often occurs in women with no identifiable ante-
partum risk factors. Risk factors in the intra-partum period
may provide opportunity for intervention, or for active
management in the early stages of PPH.
Despite the severe burden of PPH, few studies have
examined risk factors predicting PPH in developing
countries. The primary objective of this study is to inves-
tigate the ability to predict PPH by early screening of
women with selected risk factors. We hypothesize that a
combination of ante-partum and intra-partum risk fac-
tors will be associated with incidence of PPH, and that
these factors will have utility for screening and clinical
management of labor. The secondary objective of this
s t u d yi st oi d e n t i f yt h ec o m p o n e n t so fa c t i v em a n a g e -
m e n to ft h et h i r ds t a g eo fl a b o r( A M T S L )t h a th a v et h e
greatest impact on PPH incidence. AMSTL is a compo-
nent of internationally accepted clinical protocol for
obstetric management consisting of four components:
use of uterotonics, uterine massage, early cord clamping,
and cord traction. The importance of AMSTL in PPH is
well established, yet the relative importance of each com-
ponent of the process has not been examined.
Previous Research
Previous research has identified demographic, ante-par-
tum, and intra-partum risk factors that are associated
with risk of hemorrhage, but these associations are not
predictive. In addition, the majority of these studies focus
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different delivery circumstances from women in develop-
ing countries. An extensive literature review on PubMed
that investigated ante-partum and intra-partum risk fac-
tors for PPH was carried out. All of the risk factors found
are described below; citations are only for the most
recent article published on the topic.
Investigators have established myriad demographic,
ante-partum, and intra-partum risk factors. Demographic
risk factors associated with excessive blood loss (greater
than 500 or 1000 ml) in the first 24 hour after vaginal
delivery include non-white ethnicity [2], and older age [3].
Among ante-partum risk factors, history of PPH [4], his-
tory of blood disorders [2], nulliparity [5], low parity [6],
grand multiparty [7], high blood pressure [8], ante-partum
hemorrhage [9], multiple pregnancy [3], fewer than four
prenatal visits [10], lack of iron supplementation/anemia
[3], over distended uterus [5], pregnancy induced hyper-
tension [11], and increased maternal BMI [12] have been
significantly associated with PPH in previous studies.
Intra-partum risk factors may indicate a different point of
intervention than ante-partum factors. Past studies have
shown preterm birth [7], episiotomy or genital tract
trauma [11], labor augmentation or instrumental delivery
[8], use of oxytocics for induction or augmentation [7],
induction of labor [8], abnormal fetal presentation [2],
manual removal of placenta or retained placenta [11],
uterine atony [4], coagulopathy [13], placenta previa or
accreta [14], perineal tear [15], intra-partum hemorrhage
[5], non-use of oxytocics after delivery [16], birthweight
[10], placental weight [7], and perinatal death [17] to be
significantly associated with PPH.
Prolonged labor is consistently associated with PPH as
well, although studies differ on a meaningful threshold for
each stage. Stones et al. associated labor of over 12 hours
with increased risk of PPH [18]. While multiple studies
associate prolonged 1
st and 2
nd stage of labor with
increased risk of PPH, the magnitude of association for the
3
rd stage appears to be pronounced [2,5,7-9,11,14,19-26].
Despite all that is known about PPH risk factors, risk
factors associated with primary PPH are not useful in
predicting patients who will continue to bleed after first-
line therapy [27]. And while previous studies have identi-
fied significant associations among ante-partum and
intra-partum risk factors, Tsu’s paper (1993) is the only
published work examining predictive probability of
screening for PPH. While predictive values were less than
7%, she found that screening tests for maternal height,
parity, and obstetric history could identify one third of
PPH cases [28].
Methods
We conducted a secondary data analysis using data from
prospective, hospital based operations research in Egypt
in 2006. The objective of the original operations research
was to compare the current protocol for the AMTSL
with the use of 600 μg of misoprostol. The conclusion
was that misoprostol should be considered for inclusion
in the AMTSL protocol where oxytocin and or ergome-
trine are not consistently and appropriately used during
the 3
rd stage of labor. The original study was analyzed as
a pre-/post-intervention study. In the current study, we
analyzed all women who experienced PPH as ‘cases’ and
all women who did not experience PPH as ‘controls.’
Details on design data, collection, and results of the origi-
nal study are reported elsewhere [29]. Over a 6-month
period, 2532 pregnant women were recruited into the
study from three university hospitals. Inclusion criteria
were: anticipated singleton vaginal delivery, gestational
age greater than 36 weeks, and ability to give informed
consent. Women who delivered by cesarean section or
women with missing information on delivery type were
excluded from this analysis, leaving a total of 2510
women.
The primary outcome of interests was incidence of PPH.
In accordance with international clinical protocol, PPH
was defined as blood loss greater than 500 ml during the
first 4 hours after delivery. Following delivery and the
clamping of the umbilical cord, a calibrated drape was
placed under the women’s buttocks for blood loss mea-
surement. This drape remained under the women’sb u t -
tocks for 4 hours, during which time blood loss was read
cumulatively every 20 minutes. Total blood loss was estab-
lished after the bleeding had stopped. In the original study,
women in the misoprostol group were 70% less likely to
bleed 500 ml or more (OR = 0.30, 95% CI 0.16-0.56) com-
pared to those in the current practices group. In addition,
the women in the misoprostol group needed additional
interventions because of postpartum hemorrhage only
11% of the time, compared to 73% among the current
practices group.
To evaluate the value of risk factors for screening and
labor management, attending physicians collected both
ante-partum and intra-partum information using ques-
tionnaires that were completed at the time of admission,
during labor, after delivery for up to 4 hours, and before
discharge. Variables collected at the time of admission for
delivery include maternal age (30 years or older), educa-
tion (literacy), nulliparity, previous antenatal care (no care
or high number of visits compared), PPH in a previous
pregnancy, history of obstetric complications, intact mem-
branes, anemia, and cervical dilation. Anemia was mea-
sured by blood collected after enrollment, and defined as
ante-partum hemoglobin at or below 11 mg/dl.
Intra-partum variables include vaginal delivery with
instruments, episiotomy, labor augmentation, retained pla-
centa, vaginal tears, fetal macrosomia (> 3500 g), length of
1
st and 2
nd stage, and absence of AMTSL. Additionally,
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separately, including use of uterotonics in the 3
rd stage,
early cord clamping, cord traction, and uterine massage.
Ethical review for the study was provided by the Com-
mittee for the Protection of Human Subjects at the Uni-
versity of California, Berkeley and the Egyptian ethics
committees. The Healthy Mother Healthy Child Project,
which was implemented by John Snow Inc. under United
States Agency for International Development (USAID)
Contract No. 263-C-00-98-0041-00, was responsible for
study implementation. Venture Strategies for Health and
Development (VSHD) donated the misoprostol used in
the operations research (Misotac; Sigma Co., Moubarak
industrial City, First Quarter Quesna, Egypt).
Data was entered using Epi-Info version 2002 (Centers
for Disease Control and Prevention, Atlanta, Georgia,
USA), and statistical analysis was performed with the
STATA
® version 8.0 (StataCorp, LP, College Station,
Texas, USA). We constructed separate, multiple logistic
regression models for ante-partum and intra-partum vari-
ables associated with PPH, but not as a stepwise regres-
sion. Model 1 included demographic and antepartum
variables; Model 2 included intra-partum variables and
one variable to represent AMTSL; Model 3 is a variation
of Model 2 with AMTSL separated out by each compo-
nent; and the final model, Model 4, was the combination
of demographic/antepartum, intra-partum, and separated
AMTSL factors. Separating each of the four components
of AMTSL allowed us to assess the relative importance of
each component. Odds ratios were provided as the mea-
sure of effect. Results from the final model, Model 4, were
used in post-model estimation of predictive probability of
PPH. In addition, we created cumulative scores based on
the number of risk factors (1, 2, 3, or 4+). Sensitivity and
specificity were calculated for the cumulative risk factor
probabilities and for the combined measure of AMTSL.
Receiver operating curves (ROC) were derived from these
sensitivity and specificity estimates. Significant associations
were established at p-values < 0.05.
Results
The incidence of PPH among the 2510 singleton vaginal
deliveries was 3.71% (n = 93). The distribution of demo-
graphics, ante-partum, and intra-partum risk factors are
listed in Table 1. Odds ratios from bivariable analyses of
risk factors and incidence of PPH are reported along with
associated p-values and 95% confidence intervals (CIs).
Among unadjusted ante-partum variables, history of PPH
in a previous pregnancy increased the risk of PPH by
almost 69 times. Women who had one antenatal care
(ANC) visit, those with no care, and those with higher
levels of care also had an increased risk of PPH. No other
ante-partum risk factors were significant in bivariable
logistic regressions.
Among intra-partum risk factors, episiotomy, labor aug-
mentation, vaginal tears, macrosomia, and length of the
first and second stage of labor were each associated with
an increased odds of PPH. Women who did not receive
AMTSL were 8 times more likely to have PPH. When
assessed separately, omission of each component of
AMTSL was also significantly associated with PPH risk.
Table 2 shows separate adjusted multivariable models
for ante-partum risk factors (Model 1), intra-partum risk
factors, (Models 2 and 3) and a full model (Model 4) con-
taining both sets of variables. Components of AMTSL
were included separately (Model 3) and together (Model
2) in intra-partum models. Each AMTSL component was
considered individually in the full model. History of pre-
vious PPH (OR = 105.44, 95% CI 15.14-734.53), 2-3 ANC
visits (OR = 7.02, 95% CI 1.49-33.01), and over 4 ANC vis-
its (OR = 10.63, 95% CI 2.30-49.03) each remained posi-
tively associated with increased odds of PPH in the ante-
partum only model. Additionally, a multivariable intra-
partum model that considered the four components of
AMTSL combined showed that labor augmentation with
oxytocin (OR = 1.77, 95% CI 1.11-2.81), prolonged labor
(1-2.9 hours OR = 2.42, 95% CI 1.15-5.06; 3-4.9 hours OR
= 3.25, 95% CI 1.62-6.53; 5+ hours OR = 2.66, 95% CI
1.22-5.82), and AMTSL (OR = 105.44, 95% CI 15.14-
734.53) were significantly associated with risk of PPH.
When each component of AMTSL was included sepa-
rately, fetal macrosomia (OR = 1.59, 95% CI 1.01-2.50)
became marginally significant. In this model, use of utero-
tonics during the 3
rd stage of labor was the only AMTSL
component associated with PPH (OR = 9.74, 95% CI 4.58-
20.77). Episiotomy was marginally associated with PPH
risk (p = 0.08). Vaginal tears, uterine massage, cord trac-
tion, and early cord clamping, though significant in the
unadjusted analysis, were not associated with PPH after
controlling for other intra-partum risk factors.
I nt h ef u l lm u l t i v a r i a b l em o d e l( M o d e l4 ) ,w h i c h
included both ante- and intra-partum variables, elevated
number of ANC visits (2-3 visits OR = 5.89, 95% CI 1.13-
30.62; 4+ visits OR = 7.43, 95% CI 1.44-38.46), history of
PPH (OR = 305.14, 95% CI 48.02-1938.87), anemia (OR =
2.73, 95% CI 1.43-5.23), labor augmentation (OR = 2.37,
95% CI 1.14-4.93), retained placenta (OR = 21.68, 95% CI
4.41-106.54), and length of 1
st and 2
nd stage (3-4.9 hours:
OR = 4.93, 95% CI 1.55-15.70; 5+ hours: OR = 5.75, 95%
CI 1.73-19.14) remained significantly associated with
increased risk of PPH. Non-use of uterotonics in the 3
rd
third stage (OR = 11.26, 95% CI 3.91-32.47), and cord
traction (OR = 8.26, 95% CI 1.02-67.00) were the only
components of AMSTL that remained significant in the
full model.
We used post model probability estimates to predict
the probability of developing PPH with each one of the
statistically significant risk factors in Model 4 (Figure 1).
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Page 3 of 10Table 1 Distribution of ante-partum and intra-partum factors and crude odds ratios associated with PPH (blood loss
≥500 mL) for vaginal deliveries
PPH No PPH OR p-value 95% CI
93 N (%) 2417 N (%)
Ante-Partum
Age
< 30 72 (77.4) 1,892 (79.4) 1.00
30 + 21 (22.6) 492 (20.6) 1.12 0.650 (0.68, 1.84)
Education
illiterate 34 (37.8) 1,092 (45.8) 1.00
literate 56 (62.2) 1, 295 (54.2) 1.39 0.137 (0.90, 2.14)
Parity
multiparous 53 (61.6) 1,524 (64.85) 1.00
nuliparous 33 (38.4) 826 (35.15) 1.15 0.539 (0.74, 1.79)
Antenatal care
1 visit 2 (2.3) 275 (12.0) 1.00
No ANC 29 (33.3) 874 (38.1) 4.56 0.039 (1.08, 19.24)
2-3 visits 21 (24.1) 548 (23.9) 5.27 0.025 (1.22, 22.63)
4+ visits 35 (40.2) 597 (26.0) 8.06 0.004 (1.93, 33.76)
History of PPH
None 88 (94.6) 2,415 (99.9) 1.00
Prior PPH 5 (5.4) 2 (0.1) 68.61 < 0.001 (13.13, 358.51)
Previous obstetric complications
none 92 (98.9) 2,306 (95.4) 1.00
Other non-PPH 1 (1.1) 111 (4.6) 0.23 0.141 (0.03, 1.63)
Membranes
ruptured 24 (26.1) 614 (25.7) 1.00
intact 68 (73.9) 1,775 (74.3) 0.98 0.934 (0.61, 1.57)
Anemia
Ante-partum hemoglobine> 11 mg/dl 55 (74.3) 1,332 (77.8) 1.00
Ante-partum hemoglobine < = 11 mg/dl 19 (25.7) 380 (22.2) 1.21 0.480 (0.71, 2.07)
Cervical dilation on admission
up to 3 cm 4 (4.3) 161 (6.7) 1.00
4-7 cm 57 (62.0) 1,548 (64.8) 1.48 0.453 (0.53, 4.14)
> 7 cm 31 (33.7) 680 (28.5) 1.83 0.260 (0.64, 5.27)
Intra-partum
Delivery
Spontaneous delivery 92 (98.9) 2,411 (99.8) 1.00
vaginal delivery with instruments 1 (1.1) 6 (0.2) 4.37 0.174 (0.52, 36.65)
Episiotomy
no 34 (37.0) 1,328 (55.8) 1.00
yes 58 (63.0) 1,052 (44.2) 2.15 < 0.001 (1.40, 3.31)
Labor augmentation
no 44 (47.3) 1,562 (64.7) 1.00
yes 49 (52.7) 854 (35.3) 2.04 0.001 (1.34, 3.09)
Complete placenta expulsion
yes 92 (98.9) 2,395 (99.5) 1.00
no 1 (1.1) 13 (0.5) 2.00 0.506 (0.26, 15.47)
Vaginal tears
no 82 (89.1) 2,216 (95.3) 1.00
yes 10 (10.9) 110 (4.7) 2.46 0.010 (1.24, 4.87)
Fetal weights
< 3500 mg 54 (59.3) 1,692 (71.7) 1.00
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Page 4 of 10Table 1 Distribution of ante-partum and intra-partum factors and crude odds ratios associated with PPH (blood loss
?≥?500 mL) for vaginal deliveries (Continued)
Macrosomia (> 3500 mg) 37 (40.1) 667 (28.3) 1.74 0.011 (1.13, 2.67)
Length of 1st and 2nd stage
< 1 hour 10 (11.0) 634 (26.7) 1.00
1 - 2.9 hours 27 (29.7) 670 (28.2) 2.55 0.012 (1.23, 5.32)
3 - 4.9 hours 34 (37.3) 629 (26.5) 3.43 0.001 (1.68, 7.00)
5 + hours 20 (22.0) 443 (18.6) 2.86 0.007 (1.33, 6.17)
AMTSL
Yes 62 (66.7) 2,281 (94.4) 1.00
No 31 (33.3) 136 (5.63) 8.39 < 0.001 (5.27, 13.35)
AMTSL components
Use of uterotonics in 3rd stage
yes 78 (83.9) 2,333 (96.6) 1.00
no 15 (16.1) 83 (3.4) 5.40 < 0.001 (2.98, 9.79)
Early cord clamping
yes 86 (92.5) 2,376 (98.3) 1.00
no 7 (7.5) 41 (1.7) 4.72 < 0.001 (2.06, 10.82)
Cord traction
yes 85 (91.4) 2,399 (99.3) 1.00
no 8 (8.6) 18 (0.7) 12.54 < 0.001 (5.31, 29.66)
Uterine massage
yes 82 (88.2) 2,383 (98.6) 1.00
no 11 (11.8) 34 (2.4) 9.40 < 0.001 (4.60, 19.21)
Table 2 Adjusted multivariable logistic regression models for ante-partum and intra-partum risk factors associated
with PPH (blood loss ≥500 mL) for vaginal deliveries
Model 1 Model 2 Model 3 Model 4
antepartum intra-partum AMTSL Full model
OR for PPH 95% CI OR for PPH 95% CI OR for PPH 95% CI OR for PPH 95% CI
Ante-Partum
Age
< 30 1.00 - - 1.00
30 + 1.47 (0.75,
2.88)
- - 2.04 (0.92,
4.52)
Education
illiterate 0.83 - - 1.00
literate 1.00 (0.39,
1.79)
- - 0.62 (0.28,
1.42)
Parity
multiparous 1.21 - - 1.00
nuliparous 1.00 (0.67,
2.19)
- - 0.84 (0.40,
1.78)
Antenatal care
1 visit 1.00 - - 1.00
No ANC 2.67 (0.58,
12.32)
1.61 (0.30,
8.51)
2-3 visits 7.02 (1.49,
33.01)
5.89 (1.13,
30.62)
4+ visits 10.63 (2.30,
49.03)
- - 7.43 (1.44,
38.46)
History of PPH
None 1.00 - - 1.00
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Page 5 of 10Table 2 Adjusted multivariable logistic regression models for ante-partum and intra-partum risk factors associated
with PPH (blood loss ?≥?500 mL) for vaginal deliveries (Continued)
Prior PPH 105.44 (15.14,
734.53)
- - 305.14 (48.02,
1938.87)
Previous obstetric complications
none 1.00 - - 1.00
prior non-PPH complications 0.26 (0.04,
1.84)
- - 0.25 (0.02,
3.80)
Membranes
ruptured 1.00 - - 1.00
intact 1.35 (0.73,
2.50)
- - 1.06 (0.54,
2.09)
Anemia
Ante-partum hemoglobine> 11 mg/dl 1.00 - - 1.00
Ante-partum hemoglobine < = 11 mg/dl 1.76 (0.98,
3.16)
- - 2.73 (1.43,
5.23)
Cervical dilation on admission
up to 3 cm 1.00 - - 1.00
4-7 cm 3.62 (0.51,
25.77)
- - 4.60 (0.70,
30.38)
> 7 cm 3.67 (0.47,
28.62)
- - 6.34 (0.87,
45.94)
Intra-partum
Delivery
Spontaneous delivery - 1.00 1.00 1.00
vaginal delivery with instruments - 1.37 (0.13,
14.22)
1.35 (0.11,
15.87)
3.59 (0.35,
36.79)
Episiotomy
no - 1.00 1.00 1.00
yes - 1.60 (0.97,
2.63)
1.55 (0.94,
2.56)
1.72 (0.69,
4.30)
Labor augmentation
no - 1.00 1.00 1.00
yes - 1.77 (1.11,
2.81)
1.94 (1.17,
3.20)
2.37 (1.14,
4.93)
Complete placenta expulsion
yes - 1.00 1.00 1.00
no - 1.32 (0.55,
3.16)
2.91 (0.56,
15.07)
21.68 (4.41,
106.54)
Vaginal tears
no - 1.00 1.00 1.00
yes - 3.37 (0.59,
19.41)
1.70 (0.79,
3.67)
2.27 (0.94,
5.50)
Fetal weights
< 3500 mg - 1.00 1.00 1.00
Macrosomia (> 3500 mg) - 1.35 (0.85,
2.15)
1.59 (1.01,
2.50)
0.99 (0.53,
1.88)
Length of 1st and 2nd stage
< 1 hour - 1.00 1.00 1.00
1 - 2.9 hours - 2.42 (1.15, 5.06) 2.45 (1.14,
5.26)
1.95 (0.62,
6.15)
3 - 4.9 hours - 3.25 (1.62,
6.53)
3.77 (1.86,
7.65)
4.93 (1.55,
15.70)
5 + hours - 2.66 (1.22,
5.82)
3.12 (1.44,
6.74)
5.75 (1.73,
19.14)
AMTSL
Yes - 1.00 - -
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placenta each had a predictive probability of 20% or
higher.
We examined whether the percentage of women with
0, 1, 2, 3, or 4+ significant risk factors differed between
those who had PPH and those who did not (Figure 2).
Although percentages appear different for those with 0,
1, 3, and 4+ factors, the difference was only significant
among women with 3 risk factors. Post model probabil-
ity estimates showed that by screening and diagnosing
women with three risk factors, we can identify 10% of
women who will develop PPH (Figure 3). Similarly,
screening for 4 risk factors may identify 31% of women
who will develop PPH.
Table 3 presents the relative sensitivity, specificity,
likelihood ratio, and percent correctly classified for
w o m e nw i t h1 ,2 ,3 ,o r4 +r i s kf a c t o r sf o rP P H .A st h e
number of identified risk factors increases, so does per-
centage correctly classified. Perhaps because of the low
incidence of PPH in the study population, the likelihood
ratios are low for all risk factors. Women with 4+ iden-
tifiable risk factors had an LR of above 12.
Figure 4 displays the relative utility of screening
women with 1, 2, 3, or 4+ significant risk factors for
PPH. Sensitivity, or the proportion of true positives, is
high for using a screening cut point of 1 or 2 risk fac-
tors. However, the specificity, or proportion of true
negatives, is low at 9% and 47% respectively. This means
that if 1 risk factor was used as a cut point, 100% of
those who would go on to have PPH would be captured.
However, only 9% of those identified as positive would
Table 2 Adjusted multivariable logistic regression models for ante-partum and intra-partum risk factors associated
with PPH (blood loss ?≥?500 mL) for vaginal deliveries (Continued)
No - 9.44 (5.57,
16.01)
--
AMTSL components
Use of uterotonics in 3rd stage
yes - - 1.00 1.00
no - - 9.75 (4.58,
20.77)
11.26 (3.91,
32.47)
Early cord clamping
yes - - 1.00 1.00
no - - 1.36 (0.31,
6.04)
3.08 (0.52,
18.43)
Cord traction
yes - - 1.00 1.00
no - - 1.22 (0.21,
7.06)
8.26 (1.02,
67.00)
Uterine massage
yes - - 1.00 1.00
no - - 4.47 (0.94,
21.33)
0.64 (0.07,
5.58)
Figure 1 Predicted probability for risk factors significantly
associated with PPH.
Figure 2 Number of statistically significant risk factors for PPH
among women with vaginal deliveries.
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Page 7 of 10actually be positive. Thus you would have many people
who would be screened as at risk who in reality may
not be. Increasing the cut point to 2 risk factors would
decrease sensitivity only marginally, but would increase
specificity to 47%. Similarly, using 3 risk factors as a cut
point would result in few false positives, but would also
decrease sensitivity, meaning that some cases would be
missed.
Discussion
Results of this study show that most demographic and
ante-partum risk factors have little association with devel-
opment of PPH, with the exception of history of PPH, low
hemoglobin, and high usage of ANC. In addition, the pre-
dictive probability of ante-partum and intra-partum risk
factors for PPH is low, although women with four or more
identified risk factors had a predictive probability of over
30%. This probability is higher than those observed by Tsu
in Zimbabwe, and indicates that perhaps prediction of
PPH is more significantly influenced by ante-partum vari-
ables [28].
The results of this analysis confirm our hypothesis that
in vaginal, singleton deliveries, both ante-partum and
intra-partum factors are associated with the incidence of
PPH, but these associations are not predictive. Predictive
probability of PPH based on any risk factor remains low.
The exception is history of PPH, which had a predictive
probability of 70% for incidence of PPH. A high number
of antenatal care visits was also associated with increased
risk, likely because this serves as a marker for high-risk
pregnancies. The utility of screening based on number of
risk factors should be considered in conjunction with ben-
efits of positively identifying all possible cases, and costs of
over treating.
The findings of this study indicate that AMTSL signif-
icantly reduces the risk of PPH. AMTSL has been
recommended as a routine management for vaginal
deliveries in hospital settings [30,31], but it is rarely
used in Egyptian hospitals. An analysis of the manage-
ment of the third stage of labor in an Egyptian teaching
hospital showed that only 15% of the women during the
study period received correct AMTSL [32].
T oo u rk n o w l e d g e ,t h i si st h ef i r s ta n a l y s i st oe x a m i n e
the utility of each component of AMSTL separately. Our
analysis of the components of AMTSL indicates that non-
use of uterotonics in AMTSL had the strongest association
with increased odds of PPH after adjustment. Cord trac-
tion was also significantly associated with PPH after con-
trolling for other components. Uterine massage and early
cord clamping, however, appear to have no independent
effect on risk of PPH, which could be due to a lack of
variability between each component. We investigated the
variability of early cord clamping and cord traction and
found that there were some women who received one and
not the other. As a result, we decided to include both
components in the model.
This touches on an overall limitation of this analysis. As
many of the identified risk factors are correlated with one
another, collinearity of the variables may have biased our
inferences. This limitation would likely lead to conserva-
tive effect estimates, as we may be over controlling for
related factors. In order to account for covariance, we
used robust estimator of standard errors.
Low predictive probability values may have been the
result of very low incidence of PPH in the study; the inci-
dence of PPH in the study hospitals was 3.7%. Administra-
tion of uterotonics and AMTSL in the study hospitals
likely contributed to the low rate of PPH.
Despite a 52% reduction in the Egyptian maternal mor-
tality ratio (MMR) during the 1990s, PPH remained the
main cause of death. According to the National Maternal
Mortality Study [33], primary PPH alone was responsible
for 27% of all maternal deaths, making it the single most
important cause of maternal death in Egypt. High parity,
Figure 3 Predicted probability of developing PPH according to
number of statistically significant risk factors.
Table 3 Specificity and sensitivity criteria for postpartum hemorrhage
Number of risk factors Sensitivity (%) Specificity (%) Likelihood ratio % correctly classified
1 100.00 9.01 1.10 12.66
2 91.38 46.76 1.72 48.55
3 56.90 81.20 3.03 80.22
4+ 13.79 98.92 12.76 95.5
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attendants, and mismanagement of PPH contribute to
high maternal deaths in Egypt [34].
This study advances knowledge on the utility of
screening for PPH in a clinical setting. This research has
primary implications for screening and subsequent man-
agement of those at highest risk. Many of the identified
risk factors cannot be prevented or altered, but women
who present for delivery with these factors can be clo-
sely monitored, and when possible, intra-partum inter-
ventions that are significant risk factors should be
avoided.
Conclusion
While no single risk factor or combination thereof can
reliably predict risk of hemorrhage after delivery, combi-
nations of risk factors can be used for screening and
management. Given the limited utility of screening for
PPH, program planners and policy makers need to focus
on the development and enforcement of protocols for
prevention and treatment of PPH by considering the
capacity and limitations of each context. The need for
further research and policy work surrounding preven-
tion efforts is especially important due to the low pre-
dictability of PPH.
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